Christopher Worrell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christopher Worrell has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Daniel T. DeArmond
Department of Cardiothoracic Surgery, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA
1 shared publication - John Calhoon
Department of Cardiothoracic Surgery, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA
1 shared publication - Nitin A. Das
Department of Cardiothoracic Surgery, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA
1 shared publication - Sarfraz Khan
Department of Accounting, University of Louisiana at Lafayette, Lafayette, LA 70503, USA
1 shared publication - Steven D. Dallas
Department of Pathology and Laboratory Medicine, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA
1 shared publication - Stewart Robert Miller
Department of Marketing & Management, Durham University
1 shared publication
Latest Publications
- Open Access
- 27 February 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (3) , 279
Improved Peripheral Intravenous Catheter Maintenance by In-Line Mechanical Pulse
The World Health Organization (WHO) has identified infections associated with peripheral intravenous catheters (PIVCs) as a major health burden affecting patients across countries and income status categories, meriting particular attention from care providers and researchers. As many as 70% of inpatients worldwide require PIVC placement, making it one of the most commonly performed invasive procedures in current medical practice. WHO guidelines for preventing PIVC-related infections, including bloodstream infections, focus on maintaining optimal achievable local sterility of PIVCs. The closely related complication of PIVC infiltration has attracted a great deal of research and technological focus to mitigate tissue damage due to fluid or vesicant medication delivery through infiltrated PIVCs. In this study, we report a novel approach to anti-bacterial therapy in PIVCs based on applying a low-force pulse to the fluidic system encompassing a PIVC. A 60-beats-per-minute pulse was introduced by periodic compression of the intravenous tubing upstream from the PIVC, resulting in a fluid displacement of 1–3 mm through the PIVC and into the downstream vein. In the presence of a bacterial inoculum, this pulsatility prevented bacterial growth in PIVCs, as evidenced by near-elimination of colony formation in cultured PIVC flush effluent. The introduction of pulsatility also allowed for identifying PIVC infiltration or malplacement in an ex vivo model, as infiltrated or malplaced PIVCs did not permit pulse propagation. A computationally economical digital signal processing methodology for pulse analysis was employed, providing a statistically based “two-factor authentication” of PIVC non-infiltrated status. We believe the simple intervention described in this study has the potential to reduce PIVC-associated infections and improve the early detection of PIVC infiltration, thereby improving the quality of PIVC therapy.
- 27 February 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (3) , 279
Open AccessImproved Peripheral Intravenous Catheter Maintenance by In-Line Mechanical Pulse
The World Health Organization (WHO) has identified infections associated with peripheral intravenous catheters (PIVCs) as a major health burden affecting patients across countries and income status categories, meriting particular attention from care providers and researchers. As many as 70% of inpatients worldwide require PIVC placement, making it one of the most commonly performed invasive procedures in current medical practice. WHO guidelines for preventing PIVC-related infections, including bloodstream infections, focus on maintaining optimal achievable local sterility of PIVCs. The closely related complication of PIVC infiltration has attracted a great deal of research and technological focus to mitigate tissue damage due to fluid or vesicant medication delivery through infiltrated PIVCs. In this study, we report a novel approach to anti-bacterial therapy in PIVCs based on applying a low-force pulse to the fluidic system encompassing a PIVC. A 60-beats-per-minute pulse was introduced by periodic compression of the intravenous tubing upstream from the PIVC, resulting in a fluid displacement of 1–3 mm through the PIVC and into the downstream vein. In the presence of a bacterial inoculum, this pulsatility prevented bacterial growth in PIVCs, as evidenced by near-elimination of colony formation in cultured PIVC flush effluent. The introduction of pulsatility also allowed for identifying PIVC infiltration or malplacement in an ex vivo model, as infiltrated or malplaced PIVCs did not permit pulse propagation. A computationally economical digital signal processing methodology for pulse analysis was employed, providing a statistically based “two-factor authentication” of PIVC non-infiltrated status. We believe the simple intervention described in this study has the potential to reduce PIVC-associated infections and improve the early detection of PIVC infiltration, thereby improving the quality of PIVC therapy.